Commutee

U.S. top court rejects Amgen over cholesterol medication patent fight

January 7, 2019 by  
Filed under News

Amgen Inc on Monday lost its bid at the U.S. Supreme Court to overturn a ruling that kept the Regeneron Pharmaceuticals Inc and Sanofi SA cholesterol-lowering drug Praluent on the market, but the patent dispute among the rival drugmakers will continue in another trial.


Source: Reuters Business News

Comments are closed.